Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription 08.04.2024 2 Antimicrob Agents Chemother 1 Antiviral Res 1 Arch Virol 1 Biochem Biophys Res Commun 1 Biochemistry 2 BMC Pediatr 1 BMJ 1 Drugs 2 Epidemiol Infect 1 Eur J Epidemiol 4 J Infect 1 J Infect Dis 3 J Virol 2 JAMA 1 Lancet 1 MMWR Morb Mortal Wkly Rep 2 Pediatrics 1 PLoS Comput Biol 1 PLoS Genet 26 PLoS One 3 Proc Natl Acad Sci U S A 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. TANG W-F, Chang Y-H, Lin C-C, Jheng J-R, et al
   BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir.
   Antimicrob Agents Chemother. 2024;68:e0095623.
   PubMed         Abstract available
   
   
2. XU S, Esmaeili S, Cardozo-Ojeda EF, Goyal A, et al
   Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents.
   Antimicrob Agents Chemother. 2024;68:e0101523.
   PubMed         Abstract available
   
   

   
   Antiviral Res

3. RAHA JR, Kim KH, Bhatnagar N, Liu R, et al
   Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice.
   Antiviral Res. 2024;225:105877.
   PubMed         Abstract available
   
   

   
   Arch Virol

4. TRAN DH, Do HDK, Tran HT, Pham TNM, et al
   Rapid identification of SARS-CoV-2 strains via isothermal enzymatic recombinase amplification and nanopore sequencing.
   Arch Virol. 2024;169:87.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. SU L, Lou Y, Li J, Mao H, et al
   Influence of storage solution, temperature, assay time and concentration on RT-qPCR nucleic acid detection for SARS-CoV-2 detection of SARS-CoV-2 by the RT-qPCR.
   Biochem Biophys Res Commun. 2024;707:149726.
   PubMed         Abstract available
   
   

   
   Biochemistry

6. ADACHI T, Nakamura S, Michishita A, Kawahara D, et al
   RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer against SARS-CoV-2 Spike Protein.
   Biochemistry. 2024;63:906-912.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

7. KLEE B, Diexer S, Horn J, Langer S, et al
   The impact of non-pharmaceutical interventions on community non-SARS-CoV-2 respiratory infections in preschool children.
   BMC Pediatr. 2024;24:231.
   PubMed         Abstract available
   
   
8. LIU HF, Hu XZ, Huang RW, Guo ZH, et al
   Evaluation of disease severity and prediction of severe cases in children hospitalized with influenza A (H1N1) infection during the post-COVID-19 era: a multicenter retrospective study.
   BMC Pediatr. 2024;24:234.
   PubMed         Abstract available
   
   

   
   BMJ

9. FONG KJ, Summers C, Cook TM
   NHS hospital capacity during covid-19: overstretched staff, space, systems, and stuff.
   BMJ. 2024;385:e075613.
   PubMed        
   
   

   
   Drugs

10. SCHIMMEL J, Epperson LC, Aldy K, Wax P, et al
    Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry.
    Drugs. 2024;84:209-217.
    PubMed         Abstract available
    
    

    
    Epidemiol Infect

11. MBOUSSOU F, Nkamedjie P, Oyaole D, Farham B, et al
    Rapid assessment of data systems for COVID-19 vaccination in the WHO African Region.
    Epidemiol Infect. 2024;152:e50.
    PubMed         Abstract available
    
    
12. HOEG TB, Haslam A, Prasad V
    The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds.
    Epidemiol Infect. 2024;152:e51.
    PubMed         Abstract available
    
    

    
    Eur J Epidemiol

13. ROTHMAN KJ
    The public-health mindset : Review of "The public health approach - population thinking from the black death to COVID-19" by Alfredo Morabia, Johns Hopkins University Press, 2023.
    Eur J Epidemiol. 2024;39:323-324.
    PubMed        
    
    

    
    J Infect

14. SUN L, Man Q, Zhang H, Xia S, et al
    Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination.
    J Infect. 2024;88:106138.
    PubMed        
    
    
15. MORENO-TORRES V, Martinez-Urbistondo M, Calderon-Parra J, de Mendoza C, et al
    COVID-19 Mortality Amongst the Immunosuppresed.
    J Infect. 2024 Mar 11:106137. doi: 10.1016/j.jinf.2024.106137.
    PubMed        
    
    
16. MEERAUS W, Joy M, Ouwens M, Taylor KS, et al
    AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: the RAVEN cohort study.
    J Infect. 2024 Feb 29:106129. doi: 10.1016/j.jinf.2024.106129.
    PubMed         Abstract available
    
    
17. HAYWARD G, Yu LM, Little P, Gbinigie O, et al
    Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
    J Infect. 2024 Feb 29:106130. doi: 10.1016/j.jinf.2024.106130.
    PubMed         Abstract available
    
    

    
    J Infect Dis

18. RECTO C, Fourati S, Khellaf M, Pawlotsky JM, et al
    Respiratory syncytial virus vs. Influenza virus infection: mortality and morbidity comparison over 7 epidemic seasons in an elderly population.
    J Infect Dis. 2024 Apr 4:jiae171. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

19. KEOWN J, Baazaoui A, Sebesta M, Stefl R, et al
    Structural and functional characterization of the interaction between the influenza A virus RNA polymerase and the CTD of host RNA polymerase II.
    J Virol. 2024 Apr 2:e0013824. doi: 10.1128/jvi.00138.
    PubMed         Abstract available
    
    
20. SILVA F, Boal-Carvalho I, Williams N, Chabert M, et al
    Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3.
    J Virol. 2024 Apr 3:e0041124. doi: 10.1128/jvi.00411.
    PubMed         Abstract available
    
    
21. MAES A, Botzki A, Mathys J, Impens F, et al
    Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza A virus infection.
    J Virol. 2024 Apr 3:e0185723. doi: 10.1128/jvi.01857.
    PubMed         Abstract available
    
    

    
    JAMA

22. ANDERER S
    Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
    JAMA. 2024;331:1082.
    PubMed        
    
    
23. ANDERER S
    CDC Recommends Additional COVID-19 Booster for Older Adults.
    JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
    PubMed        
    
    

    
    Lancet

24. WANG X, Li Y, Shi T, Bont LJ, et al
    Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Lancet. 2024 Feb 14:S0140-6736(24)00138-7. doi: 10.1016/S0140-6736(24)00138.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

25. LINK-GELLES R, Rowley EAK, DeSilva MB, Dascomb K, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged >/=18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:271-276.
    PubMed         Abstract available
    
    

    
    Pediatrics

26. RAZZAGHI H, Forrest CB, Hirabayashi K, Wu Q, et al
    Vaccine Effectiveness Against Long COVID in Children.
    Pediatrics. 2024 Jan 16. doi: 10.1542/peds.2023-064446.
    PubMed         Abstract available
    
    
27. BURSTEIN B, Sabhaney V, Florin TA, Xie J, et al
    Presentations and Outcomes Among Infants
    Pediatrics. 2024 Mar 22:e2023064949. doi: 10.1542/peds.2023-064949.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

28. PUNG R, Russell TW, Kucharski AJ
    Detecting changes in generation and serial intervals under varying pathogen biology, contact patterns and outbreak response.
    PLoS Comput Biol. 2024;20:e1011967.
    PubMed         Abstract available
    
    

    
    PLoS Genet

29. GARG E, Arguello-Pascualli P, Vishnyakova O, Halevy AR, et al
    Canadian COVID-19 host genetics cohort replicates known severity associations.
    PLoS Genet. 2024;20:e1011192.
    PubMed         Abstract available
    
    

    
    PLoS One

30. WANG J, Wu DD, DeLorenzo C, Yang J, et al
    Examining factors related to low performance of predicting remission in participants with major depressive disorder using neuroimaging data and other clinical features.
    PLoS One. 2024;19:e0299625.
    PubMed         Abstract available
    
    
31. TOH KB, Cummings DAT, Longini IM Jr, Hladish TJ, et al
    Changing COVID-19 cases and deaths detection in Florida.
    PLoS One. 2024;19:e0299143.
    PubMed         Abstract available
    
    
32. AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
    Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
    PLoS One. 2024;19:e0301198.
    PubMed         Abstract available
    
    
33. SANDOVAL MN, McClellan SP, Pont SJ, Ross JA, et al
    Prozone masks elevated SARS-CoV-2 antibody level measurements.
    PLoS One. 2024;19:e0301232.
    PubMed         Abstract available
    
    
34. ATAL R, Bedregal P, Carrasco JA, Gonzalez F, et al
    The Impacts of COVID-19 Restrictions on Quality Adjusted Life Years (QALY): Heterogeneous effects and post-pandemic recovery.
    PLoS One. 2024;19:e0300891.
    PubMed         Abstract available
    
    
35. AZIMI H, Rezapour-Nasrabad R, Borhani F, Sadat Hoseini AS, et al
    Ethical care in patients with Covid-19: A grounded theory.
    PLoS One. 2024;19:e0300156.
    PubMed         Abstract available
    
    
36. SIDDIQUEE NA, Hamiduzzaman M, McLaren H, Patmisari E, et al
    Older women's experience with COVID-19 pandemic: A study of risk perception and coping among culturally and linguistically diverse population in South Australia.
    PLoS One. 2024;19:e0301366.
    PubMed         Abstract available
    
    
37. ANDERSEN AJ, Wallez S, Melchior M, Mary-Krause M, et al
    Our perception may not be reality: A longitudinal study of the relationship between perceived and actual change in smoking behavior.
    PLoS One. 2024;19:e0301515.
    PubMed         Abstract available
    
    
38. WORTHINGTON J, Sun Z, Fu R, Lew JB, et al
    COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study.
    PLoS One. 2024;19:e0296945.
    PubMed         Abstract available
    
    
39. WIEST C, Philipp A, Foltan M, Geismann F, et al
    Refractory circulatory failure in COVID-19 patients treated with veno-arterial ECMO a retrospective single-center experience.
    PLoS One. 2024;19:e0298342.
    PubMed         Abstract available
    
    
40. IBNE ZAID Z, Tasnim A, Haque Khan MM, Ahmed Ratan Z, et al
    Common mental health problems and associated factors among recovered COVID-19 patients in rural area: A community-based survey in Bangladesh.
    PLoS One. 2024;19:e0294495.
    PubMed         Abstract available
    
    
41. SCODITTI E, Bodini A, Sabina S, Leo CG, et al
    Effects of working from home on lifestyle behaviors and mental health during the COVID-19 pandemic: A survey study.
    PLoS One. 2024;19:e0300812.
    PubMed         Abstract available
    
    
42. MUGO C, Adedokun O, Alo OD, Ezeokafor N, et al
    Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
    PLoS One. 2024;19:e0300335.
    PubMed         Abstract available
    
    
43. LEKSY K, Gawron G, Rosario R
    Associations between Polish school principals' health literacy and implementation of the Health Promoting School approach during the COVID-19 pandemic.
    PLoS One. 2024;19:e0301055.
    PubMed         Abstract available
    
    
44. LUBIS FY, Abidin FA, Qodariah L, Anindhita V, et al
    Coping strategies and psychological distress among mothers during COVID-19 pandemic: The moderating role of social support.
    PLoS One. 2024;19:e0300365.
    PubMed         Abstract available
    
    
45. LOUIE-POON S, Reid K, Appiah PO, Hartling L, et al
    "There is a strangeness in this disease": A qualitative study of parents' experiences caring for a child diagnosed with COVID-19.
    PLoS One. 2024;19:e0300146.
    PubMed         Abstract available
    
    
46. ECHEVERRI TRIBIN F, Williams E, Testamarck V, Carreno JM, et al
    Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort.
    PLoS One. 2024;19:e0292566.
    PubMed         Abstract available
    
    
47. JONSSON F, Olofsson B, Soderberg S, Niklasson J, et al
    Association between the COVID-19 pandemic and mental health in very old people in Sweden.
    PLoS One. 2024;19:e0299098.
    PubMed         Abstract available
    
    
48. ORELLANA JDY, Leventhal DGP, Flores-Quispe MDP, Marrero L, et al
    Impact of the COVID-19 pandemic on excess maternal deaths in Brazil: A two-year assessment.
    PLoS One. 2024;19:e0298822.
    PubMed         Abstract available
    
    
49. ODUNYEMI A, Sohrabi H, Alam K
    The evolution of household forgone essential care and its determinants during the COVID-19 pandemic in Nigeria: A longitudinal analysis.
    PLoS One. 2024;19:e0296301.
    PubMed         Abstract available
    
    
50. ONUMAH EE, Ketadzo B, Adaku AA, Onumah JA, et al
    COVID-19 and its impact on the profit of mango value chain actors.
    PLoS One. 2024;19:e0299572.
    PubMed         Abstract available
    
    
51. PURWONO PB, Vacharathit V, Manopwisedjaroen S, Ludowyke N, et al
    Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells.
    PLoS One. 2024;19:e0301330.
    PubMed         Abstract available
    
    
52. ZAND MS, Spallina S, Ross A, Zandi K, et al
    Ventilation during COVID-19 in a school for students with intellectual and developmental disabilities (IDD).
    PLoS One. 2024;19:e0291840.
    PubMed         Abstract available
    
    
53. CHOI DE, Kim DK, Park S, Lee SH, et al
    Clinical characteristics and prognosis of patients with COVID-19 on mechanical ventilation undergoing continuous renal replacement therapy.
    PLoS One. 2024;19:e0297344.
    PubMed         Abstract available
    
    
54. MINELLO G, Santagiustina CRMA, Warglien M
    LDA2Net Digging under the surface of COVID-19 scientific literature topics via a network-based approach.
    PLoS One. 2024;19:e0300194.
    PubMed         Abstract available
    
    
55. LIU L, Zhou X, Xu J
    Does working capital management improve financial performance in China's agri-food sector during COVID-19? A comparison with the 2008 financial crisis.
    PLoS One. 2024;19:e0300217.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

56. OTTER CJ, Bracci N, Parenti NA, Ye C, et al
    SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
    Proc Natl Acad Sci U S A. 2024;121:e2320194121.
    PubMed         Abstract available
    
    
57. TAN TJC, Verma AK, Odle A, Lei R, et al
    Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike.
    Proc Natl Acad Sci U S A. 2024;121:e2317222121.
    PubMed         Abstract available
    
    
58. BABOUN J, Beaudry IS, Castro LM, Gutierrez F, et al
    Identifying outbreaks in sewer networks: An adaptive sampling scheme under network's uncertainty.
    Proc Natl Acad Sci U S A. 2024;121:e2316616121.
    PubMed         Abstract available
    
    

    
    Vaccine

59. BAUM HE, Thirard R, Halliday A, Baos S, et al
    Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial.
    Vaccine. 2024 Apr 4:S0264-410X(24)00367-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virology

60. BRIGGS K, Chrzastek K, Segovia K, Mo J, et al
    Genetic insertion of mouse Myxovirus-resistance gene 1 increases innate resistance against both high and low pathogenic avian influenza virus by significantly decreasing replication in chicken DF1 cell line.
    Virology. 2024;595:110066.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.